watch nowArtificial intelligence for cancer screening has taken off. So, it is quite a challenge," said Brittany Berry-Pusey, CEO of AI screening startup Avenda Health. Nearly 600 of them have been radiology AI applications approved in the last five years. Thorwarth wrote that AI reimbursement is complex and establishing billing codes for every approved AI tool is "problematic." RadNet's executives compare the process with AI screening to the radiology industry's experience with digital breast Tomosynthesis, known as 3D mammography.

---

Persons: Brittany Berry, Pusey, Porte, Julien De Rosa, Berry, William Thorwarth, Thorwarth, mammography, Rodrigo Cerda, Cerda, RadNet, Greg Sorensen, RadNet's, Sorensen Organizations: FDA, Food and Drug Administration, Porte de, Afp, Getty, American Medical Association, American College of Radiology, Centers, Medicare, Medicaid Services, CNBC, Artificial Intelligence, Blue Cross Locations: Paris, New Jersey